Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74:2913–21.
Article
CAS
PubMed
Google Scholar
El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology. 2012;142:1264–73.
Article
PubMed
PubMed Central
Google Scholar
Tsai WL, Chung RT. Viral hepatocarcinogenesis. Oncogene. 2010;29:2309–24.
Article
CAS
PubMed
PubMed Central
Google Scholar
Fung J, Lai CL, Yuen MF. Hepatitis B and C virus-related carcinogenesis. Clin Microbiol Infect. 2009;15:964–70.
Article
CAS
PubMed
Google Scholar
Chisari FV, Isogawa M, Wieland SF. Pathogenesis of hepatitis B virus infection. Pathol Biol. 2010;58:258–66.
Article
CAS
PubMed
PubMed Central
Google Scholar
Rogler CE, Chisari FV. Cellular and molecular mechanisms of hepatocarcinogenesis. Sem Liver Dis. 1992;12:265–78.
Article
CAS
Google Scholar
Murakami Y, Saigo K, Takashima H, Minami M, Okanoue T, Bréchot C, Paterlini-Bréchot P. Large scaled analysis of hepatitis B virus (HBV) DNA integration in HBV related hepatocellular carcinomas. Gut. 2005;54:1162–68.
Article
CAS
PubMed
PubMed Central
Google Scholar
Jiang Z, Jhunjhunwala S, Liu J, Haverty PM, Kennemer MI, Guan Y, Lee W, Carnevali P, Stinson J, Johnson S, et al. The effects of hepatitis B virus integration into the genomes of hepatocellular carcinoma patients. Genome Res. 2012;22:593–601.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bralet MP, Régimbeau JM, Pineau P, Dubois S, Loas G, Degos F, Valla D, Belghiti J, Degott C, Terris B. Hepatocellular carcinoma occurring in nonfbrotic liver: epidemiologic and histopathologic analysis of 80 French cases. Hepatology. 2000;32:200–4.
Article
CAS
PubMed
Google Scholar
Heindryckx F, Colle I, Vlierberghe HV. Experimental mouse models for hepatocellular carcinoma research. Int J Exp Pathol. 2009;90:367–86.
Article
CAS
PubMed
PubMed Central
Google Scholar
Berasain C, Goñi S, Castillo J, Latasa MU, Prieto J, Ávila MA. Impairment of pre-mRNA splicing in liver disease: Mechanisms and consequences. World J Gastroenterol. 2010;16:3091–102.
Article
CAS
PubMed
PubMed Central
Google Scholar
Black DL. Mechanisms of alternative pre-messenger RNA splicing. Annu Rev Biochem. 2003;72:291–336.
Article
CAS
PubMed
Google Scholar
Boise LH, González-García M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nuñez G, Thompson CB. Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell. 1993;74:597–608.
Article
CAS
PubMed
Google Scholar
Faustino NA, Cooper TA. Pre-mRNA splicing and human disease. Genes Dev. 2003;17:419–37.
Article
CAS
PubMed
Google Scholar
Bonomi S, Gallo S, Catillo M, Pignataro D, Biamonti G, Ghigna C. Oncogenic alternative splicing switches: role in cancer progression and prospects for therapy. Int J Cell Biol. 2013;2013:962038.
Article
PubMed
PubMed Central
Google Scholar
Bechara EG, Sebestyén E, Bernardis I, Eyras E, Valcárcel J. RBM5, 6, and 10 differentially regulate NUMB alternative splicing to control cancer cell proliferation. Mol Cell. 2013;52:720–33.
Article
CAS
PubMed
Google Scholar
Brosseau JP, Lucier JF, Lamarche AA, Shkreta L, Gendron D, Lapointe E, Thibault P, Paquet E, Perreault JP, Abou Elela S, et al. Redirecting splicing with bifunctional oligonucleotides. Nucleic Acids Res. 2014;42:e40.
Article
CAS
PubMed
Google Scholar
Saito Y, Kanai Y, Sakamoto M, Saito H, Ishii H, Hirohashi S. Overexpression of a splice variant of DNA methyltransferase 3b, DNMT3b4, associated with DNA hypomethylation on pericentromeric satellite regions during human hepatocarcinogenesis. Proc Natl Acad Sci U S A. 2002;99:10060–65.
Article
CAS
PubMed
PubMed Central
Google Scholar
Liu Z, Hou J. Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Dual Infection. Int J Med Sci. 2006;3:57–62.
Article
PubMed
PubMed Central
Google Scholar
Grosso AR, Martins S, Carmo-Fonseca M. The emerging role of splicing factors in cancer. EMBO Rep. 2008;9:1087–93.
Article
CAS
PubMed
PubMed Central
Google Scholar
Fackenthal JD, Godley LA. Aberrant RNA splicing and its functional consequences in cancer cells. Dis Model Mech. 2008;1:37–42.
Article
CAS
PubMed
PubMed Central
Google Scholar
Warzecha CC, Shen S, Xing Y, Carstens RP. The epithelial splicing factors ESRP1 and ESRP2 positively and negatively regulate diverse types of alternative splicing events. RNA Biol. 2009;6:546–62.
Article
CAS
PubMed
PubMed Central
Google Scholar
Venables JP, Koh CS, Froehlich U, Lapointe E, Couture S, Inkel L, Bramard A, Paquet ER, Watier V, Durand M, Lucier JF, Gervais-Bird J, Tremblay K, Prinos P, Klinck R, Elela SA, Chabot B. Multiple and specific mRNA processing targets for the major human hnRNP proteins. Mol Cell Biol. 2008;28:6033–43.
Article
CAS
PubMed
PubMed Central
Google Scholar
Schwerk C, Schulze-Osthoff K. Regulation of apoptosis by alternative pre-mRNA splicing. Mol Cell. 2005;19:1–13.
Article
CAS
PubMed
Google Scholar
Qin LX, Tang ZY. The prognostic molecular markers in hepatocellular carcinoma. World J Gastroenterol. 2002;8:385–92.
Article
CAS
PubMed
PubMed Central
Google Scholar
Geng M, Xin X, Bi LQ, Zhou LT, Liu XH. Molecular mechanism of hepatitis B virus X protein function in hepatocarcinogenesis. World J Gastroenterol. 2015;21:10732–38.
Article
CAS
PubMed
PubMed Central
Google Scholar
Stamm S, Smith C, Luhrmann R, editors. Alternative Pre-mRNA Splicing: Theory and Protocols. Germany: Wiley-Blackwell; 2012. eScholarID:158349.
Google Scholar
Pawellek A, McElroy S, Samatov T, Mitchell L, Woodland A, Ryder U, Gray D, Lührmann R, Lamond AI. Identification of small molecule inhibitors of pre-mRNA splicing. J Biol Chem. 2014;289:34683–98.
Article
PubMed
PubMed Central
Google Scholar
Convertini P, Shen M, Potter PM, Palacios G, Lagisetti C, de la Grange P, et al. Sudemycin E influences alternative splicing and changes chromatin modifications. Nucleic Acids Res. 2014;42:4947–61.
Article
CAS
PubMed
PubMed Central
Google Scholar
Liu X, Biswas S, Berg MG, Antapli CM, Xie F, Wang Q, Tang MC, Tang GL, Zhang L, Dreyfuss G, Cheng YQ. Genomics-guided discovery of thailanstatins A, B, and C As pre-mRNA splicing inhibitors and antiproliferative agents from Burkholderia thailandensis MSMB43. J Nat Prod. 2013;76:685–93.
Article
CAS
PubMed
PubMed Central
Google Scholar
Klinck R, Bramard A, Inkel L, Dufresne-Martin G, Gervais-Bird J, Madden R, Paquet ER, Koh C, Venables JP, Prinos P, et al. Multiple alternative splicing markers for ovarian cancer. Cancer Res. 2015;68:657–63.
Article
Google Scholar
Mellacheruvu D, Wright Z, Couzens AL, Lambert JP, St-Denis NA, Li T, Miteva YV, Hauri S, Sardiu ME, Low TY, et al. The CRAPome: a contaminant repository for affinity purification-mass spectrometry data. Nat Methods. 2013;10:730–6.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhao YJ, Ju Q, Li GC. Tumor markers for hepatocellular carcinoma. Mol Clin Oncol. 2013;1:593–98.
CAS
PubMed
PubMed Central
Google Scholar
Shirakawa H, Kuronuma T, Nishimura Y, Hasebe T, Nakano M, Gotohda N, Takahashi S, Nakagohri T, Konishi M, Kobayashi N, et al. Glypican-3 is a useful diagnostic marker for a component of hepatocellular carcinoma in human liver cancer. Int J Oncol. 2009;34:649–56.
CAS
PubMed
Google Scholar
Garber K. Energy deregulation: Licensing tumors to grow. Science. 2006;312:1158–59.
Article
CAS
PubMed
Google Scholar
Jones RG, Thompson CB. Tumor suppressors and cell metabolism: a recipe for cancer growth. Genes Dev. 2009;23:537–48.
Article
CAS
PubMed
PubMed Central
Google Scholar
Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P, Mankoo P, Carter H, Siu IM, Gallia GL, et al. An integrated genomic analysis of human glioblastoma multiforme. Science. 2008;321:1807–12.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lee CH, Wu DC, Wu IC, Goan YG, Lee JM, Chou SH, Chan TF, Huang HL, Hung YH, Huang MC, et al. Genetic modulation of ADH1B and ALDH2 polymorphisms with regard to alcohol and tobacco consumption for younger aged esophageal squamous cell carcinoma diagnosis. Int J Cancer. 2009;125:1134–42.
Article
CAS
PubMed
Google Scholar
Mamtani M, Kulkarni H. Association of HADHA expression with the risk of breast cancer: targeted subset analysis and meta-analysis of microarray data. BMC Res Notes. 2012;5:25.
Article
CAS
PubMed
PubMed Central
Google Scholar
Matlin AJ, Clark F, Smith CW. Understanding alternative splicing: towards a cellular code. Nat Rev Mol Cell Biol. 2005;6:386–98.
Article
CAS
PubMed
Google Scholar
Karni R, de Stanchina E, Lowe SW, Sinha R, Mu D, Krainer AR. The gene encoding the splicing factor SF2/ASF is a proto-oncogene. Nat Struct Mol Biol. 2007;14:185–93.
Article
CAS
PubMed
PubMed Central
Google Scholar
Anczuków O, Rosenberg AZ, Akerman M, Das S, Zhan L, Karni R, Muthuswamy SK, Krainer AR. The splicing factor SRSF1 regulates apoptosis and proliferation to promote mammary epithelial cell transformation. Nat Struct Mol Biol. 2012;19:220–28.
Article
PubMed
PubMed Central
Google Scholar
Warzecha CC, Carstens RP. Complex changes in alternative pre-mRNA splicing play a central role in the epithelial-to-mesenchymal transition (EMT). Semin Cancer Biol. 2012;22:417–27.
Article
CAS
PubMed
PubMed Central
Google Scholar
Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell. 2009;139:871–90.
Article
CAS
PubMed
Google Scholar
LaGamba D, Nawshad A, Hay ED. Microarray analysis of gene expression during epithelial-mesenchymal transformation. Dev Dyn. 2005;234:132–42.
Article
CAS
PubMed
Google Scholar
Warzecha CC, Sato T, Nabet B, Hogenesch JB, Carstens RP. ESRP1 and ESRP2 are epithelial cell-type-specific regulators of FGFR2 splicing. Mol Cell. 2009;33:591–601.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ishii H, Saitoh M, Sakamoto K, Kondo T, Katoh R, Tanaka S, Motizuki M, Masuyama K, Miyazawa K. Epithelial splicing regulatory proteins 1 (ESRP1) and 2 (ESRP2) suppress cancer cell motility via different mechanisms. J Biol Chem. 2014;289:27386–99.
Article
CAS
PubMed
PubMed Central
Google Scholar
van Zijl F, Zulehner G, Petz M, Schneller D, Kornauth C, Hau M, Machat G, Grubinger M, Huber H, Mikulits W. Epithelial-mesenchymal transition in hepatocellular carcinoma. Future Oncol. 2009;5:1169–79.
Article
PubMed
Google Scholar
Mehta S, Shelling A, Muthukaruppan A, Lasham A, Blenkiron C, Laking G, Print C. Predictive and prognostic molecular markers for cancer medicine. Ther Adv Med Oncol. 2010;2:125–48.
Article
CAS
PubMed
PubMed Central
Google Scholar
Barboro P, Repaci E, Rubagotti A, Salvi S, Boccardo S, Spina B, Truini M, Introini C, Puppo P, Ferrari N, et al. Heterogeneous nuclear ribonucleoprotein K: altered pattern of expression associated with diagnosis and prognosis of prostate cancer. Br J Cancer. 2009;100:1608–16.
Article
CAS
PubMed
PubMed Central
Google Scholar
Chen LC, Hsueh C, Tsang NM, Liang Y, Chang KP, Hao SP, Yu JS, Chang YS. Heterogeneous ribonucleoprotein K and thymidine phosphorylase are independent prognostic and therapeutic markers for nasopharyngeal carcinoma. Clin Cancer Res. 2008;14:3807–13.
Article
CAS
PubMed
Google Scholar
Kumar M, Matta A, Masui O, Srivastava G, Kaur J, Thakar A, Shukla NK, RoyChoudhury A, Sharma M, Walfish PG, et al. Nuclear heterogeneous nuclear ribonucleoprotein D is associated with poor prognosis and interactome analysis reveals its novel binding partners in oral cancer. J Transl Med. 2015;13:285.
Article
PubMed
PubMed Central
Google Scholar
Bruix J, Llovet JM. Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology. 2002;35:519–24.
Article
PubMed
Google Scholar
Bauman JA, Kole R. Modulation of RNA splicing as a potential treatment for cancer. Bioeng Bugs. 2011;2:125–28.
Article
PubMed
PubMed Central
Google Scholar
Langmead B, Salzberg S. Fast gapped-read alignment with Bowtie 2. Nature Met. 2012;9:357–35.
Article
CAS
Google Scholar
Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci U S A. 2003;100:9440–5.
Article
CAS
PubMed
PubMed Central
Google Scholar
Jiao X, Sherman BT, Huang DW, Stephens R, Baseler MW, Lane HC, Lempicki RA. DAVID-WS: a stateful web service to facilitate gene/protein list analysis. Bioinformatics. 2012;28:1805–06.
Article
CAS
PubMed
PubMed Central
Google Scholar
Szklarczyk D, Franceschini A, Wyder S, Forslund K, Heller D, Huerta-Cepas J, Simonovic M, Roth A, Santos A, Tsafou KP, et al. STRING v10: protein–protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 2015;43:D447–52.
Article
PubMed
Google Scholar
Artimo P, Jonnalagedda M, Arnold K, Baratin D, Csardi G, de Castro E, Duvaud S, Flegel V, Fortier A, Gasteiger E, et al. ExPASy: SIB bioinformatics resource portal. Nucleic Acids Res. 2012;40:W597–603.
Article
CAS
PubMed
PubMed Central
Google Scholar
Corpet F. Multiple sequence alignment with hierarchical clustering. Nucleic Acids Res. 1988;16:10881–90.
Article
CAS
PubMed
PubMed Central
Google Scholar
Finn RD, Bateman A, Clements J, Coggill P, Eberhardt RY, Eddy SR, Heger A, Hetherington K, Holm L, Mistry J, et al. The Pfam protein families database. Nucleic Acids Res. 2014;42:D222–30.
Article
CAS
PubMed
Google Scholar
Kosugi S, Hasebe M, Tomita M, Yanagawa H. Systematic identification of cell cycle-dependent yeast nucleocytoplasmic shuttling proteins by prediction of composite motifs. Proc Natl Acad Sci U S A. 2009;106:10171–76.
Article
CAS
PubMed
PubMed Central
Google Scholar
Drissi M, Dubois ML, Douziech M, Boisvert FM. Quantitative Proteomics Reveals Dynamic Interactions of the Minichromosome Maintenance Complex (MCM) in the Cellular Response to Etoposide Induced DNA Damage. Mol Cell Proteomics. 2015;14:2002–13.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhao M, Kim P, Mitra R, Zhao J, Zhao Z. TSGene 2.0: an updated literature-based knowledgebase for tumor suppressor genes. Nucleic Acids Res. 2016;44(D1):D1023–31.
Berglund L, Björling E, Oksvold P, Fagerberg L, Asplund A, Szigyarto CA, Persson A, Ottosson J, Wernérus H, Nilsson P, Lundberg E, Sivertsson A, et al. A genecentric Human Protein Atlas for expression profiles based on antibodies. Mol Cell Proteomics. 2008;10:2019–27.
Article
Google Scholar